TY - STD TI - The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia [Internet]. 2013;33(9):629–808. ID - ref1 ER - TY - STD TI - Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018;17(2):174–82. ID - ref2 ER - TY - STD TI - Stewart WF, Wood C, Reed ML, Roy J, Lipton RB. Cumulative lifetime migraine incidence in women and men. Cephalalgia. 2008;28(11):1170–8. ID - ref3 ER - TY - STD TI - Somerville BW. The influence of progesterone and estradiol upon migraine. Headache. 1972;12(3):93–102. ID - ref4 ER - TY - STD TI - Somerville BW. A study of migraine in pregnancy. Neurology. 1972;22(8):824–8. ID - ref5 ER - TY - STD TI - MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology. 2006;67(12):2154–8. ID - ref6 ER - TY - STD TI - Martin VT, Pavlovic J, Fanning KM, Buse DC, Reed ML, Lipton RB. Perimenopause and Menopause Are Associated with High Frequency Headache in Women with Migraine: Results of the American Migraine Prevalence and Prevention Study. Headache. 2016;56(2):292–305. ID - ref7 ER - TY - STD TI - Ripa P, Ornello R, Degan D, Tiseo C, Stewart J, Pistoia F, et al. Migraine in menopausal women: a systematic review. Int J Womens Health. 2015;7:773–82. ID - ref8 ER - TY - STD TI - MacGregor EA. Migraine headache in perimenopausal and menopausal women. Curr Pain Headache Rep. 2009;13(5):399–403. ID - ref9 ER - TY - STD TI - MacGregor EA. Migraine, menopause and hormone replacement therapy. Post Reprod Health. 2018;24(1):11–8. ID - ref10 ER - TY - STD TI - Nappi RE, Berga SL. Migraine and reproductive life. Handb Clin Neurol. 2010;97:303–22. ID - ref11 ER - TY - STD TI - Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–9. ID - ref12 ER - TY - STD TI - Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2013;53(8):1278–99. ID - ref13 ER - TY - STD TI - Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015;55(1):21–34. ID - ref14 ER - TY - STD TI - Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 2006;5(2):148–57. ID - ref15 ER - TY - STD TI - Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. W.B. Saunders. 2019;37:631–49. ID - ref16 ER - TY - STD TI - Stovner LJ, Nichols E, Steiner TJ, Abd-Allah F, Abdelalim A, Al-Raddadi RM, et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954–76. ID - ref17 ER - TY - STD TI - Befus DR, Irby MB, Coeytaux RR, Penzien DB. A critical exploration of migraine as a health disparity: the imperative of an equity-oriented, intersectional approach. Curr Pain Headache Rep. 2018;22(12):79. ID - ref18 ER - TY - STD TI - Loder S, Sheikh HU, Loder E. The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from National Survey studies. Headache. 2015;55(2):214–28. ID - ref19 ER - TY - STD TI - Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol. 1995;24(3):612–8. ID - ref20 ER - TY - STD TI - MacGregor EA. Classification of perimenstrual headache: clinical relevance. Curr Pain Headache Rep. 2012;16(5):452–60. ID - ref21 ER - TY - STD TI - Loder EW. Menstrual migraine: pathophysiology, diagnosis, and impact. Headache. 2006;46(Suppl 2):S55–60. ID - ref22 ER - TY - STD TI - Vetvik KG, Macgregor EA, Lundqvist C, Russell MB. Prevalence of menstrual migraine: a population-based study. Cephalalgia. 2014;34(4):280–8. ID - ref23 ER - TY - STD TI - Macgregor EA. Menstrual migraine: therapeutic approaches. Ther Adv Neurol Disord. 2009;2(5):327–36. ID - ref24 ER - TY - STD TI - Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27(5):394–402. ID - ref25 ER - TY - STD TI - Pavlovic JM, Buse DC, Sollars CM, Haut S, Lipton RB. Trigger factors and premonitory features of migraine attacks: Summary of studies. Headache. 2014;54(10):1670–9. ID - ref26 ER - TY - STD TI - Martin VT, Lipton RB. Epidemiology and biology of menstrual migraine. Headache. 48(Suppl 3):S124–30. ID - ref27 ER - TY - STD TI - Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 2000;55(10):1517–23. ID - ref28 ER - TY - STD TI - Somerville BW. Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology. 1975;25(3):239–44. ID - ref29 ER - TY - STD TI - Somerville BW. Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration. Neurology. 1975;25(3):245–50. ID - ref30 ER - TY - STD TI - Epstein MT, Hockaday JM, Hockaday TD. Migraine and reporoductive hormones throughout the menstrual cycle. Lancet. 1975;1(7906):543–8. ID - ref31 ER - TY - STD TI - Horth CE, Wainscott G, Neylan C, Wilkinson MI. Proceedings: Progesterone, oestradiol and aldosterone levels in plasma during the menstrual cycle of women suffering from migraine. J Endocrinol. 1975;65(3):24P–5P. ID - ref32 ER - TY - STD TI - Martin VT, Wernke S, Mandell K, Ramadan N, Kao L, Bean J, et al. Defining the relationship between ovarian hormones and migraine headache. Headache. 2005;45(9):1190–201. ID - ref33 ER - TY - STD TI - Ibrahimi K, van Oosterhout WPJ, van Dorp W, Danser AHJ, Garrelds IM, Kushner SA, et al. Reduced trigeminovascular cyclicity in patients with menstrually related migraine. Neurology. 2015;84(2):125–31. ID - ref34 ER - TY - STD TI - Pavlović JM, Allshouse AA, Santoro NF, Crawford SL, Thurston RC, Neal-Perry GS, et al. Sex hormones in women with and without migraine. Neurology. 2016;87(1):49–56. ID - ref35 ER - TY - STD TI - Lichten EM, Lichten JB, Whitty A, Pieper D. The confirmation of a biochemical marker for women’s hormonal migraine: the depo-estradiol challenge test. Headache. 1996;36(6):367–71. ID - ref36 ER - TY - STD TI - Robbins MS. Headache in Pregnancy. Continuum (Minneap Minn). 2018;24(4, Headache):1092–107. ID - ref37 ER - TY - STD TI - Dodick DW. Review of comorbidities and risk factors for the development of migraine complications (infarct and chronic migraine). Cephalalgia. 2009;29(Suppl 3):7–14. ID - ref38 ER - TY - STD TI - Pavlović JM, Stewart WF, Bruce CA, Gorman JA, Sun H, Buse DC, et al. Burden of migraine related to menses: Results from the AMPP study. J Headache Pain. 2015;16. https://doi.org/10.1186/s10194-015-0503-y. ID - ref39 ER - TY - STD TI - Granella F, Sances G, Allais G, Nappi RE, Tirelli A, Benedetto C, et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia. 2004;24(9):707–16. ID - ref40 ER - TY - STD TI - Pinkerman B, Holroyd K. Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine. Cephalalgia. 2010;30(10):1187–94. ID - ref41 ER - TY - STD TI - Calhoun A, Ford S. Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse. Headache. 2008;48(8):1186–93. ID - ref42 ER - TY - STD TI - MacGregor EA, Victor TW, Hu X, Xiang Q, Puenpatom RA, Chen W, et al. Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial. Headache. 2010;50(4):528–38. ID - ref43 ER - TY - STD TI - Calhoun AH. Understanding Menstrual Migraine. Headache. 2018;58(4):626–30. ID - ref44 ER - TY - STD TI - Lipton RB, Stewart WF, Celentano DD, Reed ML. Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis. Arch Intern Med. 1992;152(6):1273–8. ID - ref45 ER - TY - STD TI - Wang S-J, Fuh J-L, Lu S-R, Juang K-D, Wang P-H. Migraine prevalence during menopausal transition. Headache. 2003;43(5):470–8. ID - ref46 ER - TY - STD TI - Kravitz HM, Schott LL, Joffe H, Cyranowski JM, Bromberger JT. Do anxiety symptoms predict major depressive disorder in midlife women? The Study of Women’s Health Across the Nation (SWAN) Mental Health Study (MHS). Psychol Med. 2014;44(12):2593–602. ID - ref47 ER - TY - JOUR AU - Greenblum, C. A. AU - Rowe, M. A. AU - Neff, D. F. AU - Greenblum, J. S. PY - 2013 DA - 2013// TI - Midlife women: symptoms associated with menopausal transition and early postmenopause and quality of life JO - Menopause VL - 20 UR - https://doi.org/10.1097/gme.0b013e31825a2a91 DO - 10.1097/gme.0b013e31825a2a91 ID - Greenblum2013 ER - TY - JOUR AU - Seritan, A. L. AU - Iosif, A. M. AU - Park, J. H. AU - Deatheragehand, D. AU - Sweet, R. L. AU - Gold, E. B. PY - 2010 DA - 2010// TI - Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center JO - Menopause VL - 17 UR - https://doi.org/10.1097/gme.0b013e3181bf5a62 DO - 10.1097/gme.0b013e3181bf5a62 ID - Seritan2010 ER - TY - STD TI - Harlow SD, Karvonen-Gutierrez C, Elliott MR, Bondarenko I, Avis NE, Bromberger JT, et al. It is not just menopause: symptom clustering in the Study of Women’s Health Across the Nation. Womens Midlife Health. 2017;3:2. ID - ref50 ER - TY - STD TI - Shaver JL, Woods NF. Sleep and menopause: a narrative review. Menopause. 2015;22(8):899–915. ID - ref51 ER - TY - STD TI - Wöber C, Brannath W, Schmidt K, Kapitan M, Rudel E, Wessely P, et al. Prospective analysis of factors related to migraine attacks: the PAMINA study. Cephalalgia. 2007;27(4):304–14. ID - ref52 ER - TY - STD TI - Maleki N, Cheng Y-C, Tu Y, Locascio JJ. Longitudinal course of vasomotor symptoms in perimenopausal migraineurs. Ann Neurol. 2019;85(6):865–74. ID - ref53 ER - TY - STD TI - Neri I, Granella F, Nappi R, Manzoni GC, Facchinetti F, Genazzani AR. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas. 1993;17(1):31–7. ID - ref54 ER - TY - STD TI - Martin V, Wernke S, Mandell K, Zoma W, Bean J, Pinney S, et al. Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache. 2003;43(4):309–21. ID - ref55 ER - TY - STD TI - MacGregor EA, van den Brink AM. Transgender and Migraine. In: van den Brink AM, MacGregor E, editiors. Gender and Migraine. Headache. Cham: Springer; 2019. https://doi.org/10.1007/978-3-030-02988-3_9. ID - ref56 ER - TY - STD TI - B. N. Headache in transgendered patients. Cephalalgia. Abstract reports. 2015;35(6). ID - ref57 ER - TY - STD TI - Nicholson RA, Buse DC, Andrasik F, Lipton RB. Nonpharmacologic treatments for migraine and tension-type headache: how to choose and when to use. Curr Treat Options Neurol. 2011;13(1):28–40. ID - ref58 ER - TY - STD TI - Calhoun AH. Menstrual Migraine: Update on Pathophysiology and Approach to Therapy and Management. Curr Treat Options Neurol. 2012;14(1):1–14. ID - ref59 ER - TY - STD TI - Yuan H, Spare NM, Silberstein SD. Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review. Headache. 2019;59(Suppl 2):20–32. ID - ref60 ER - TY - STD TI - Callan NGL, Woods NF. Multifactorial: pain in the menopause transition. Menopause. 2018;25(9):965–7. ID - ref61 ER - TY - STD TI - Gibson CJ, Li Y, Huang AJ, Rife T, Seal KH. Menopausal Symptoms and Higher Risk Opioid Prescribing in a National Sample of Women Veterans with Chronic Pain. J Gen Intern Med. 2019;34(10):2159–66. ID - ref62 ER - TY - STD TI - Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48(8):1157–68. ID - ref63 ER - TY - STD TI - MacGregor A. Effects of oral and transdermal estrogen replacement on migraine. Cephalalgia. 1999;19(2):124–5. ID - ref64 ER - TY - STD TI - Aegidius KL, Zwart J-A, Hagen K, Schei B, Stovner LJ. Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study. Eur J Neurol. 2007;14(1):73–8. ID - ref65 ER - TY - STD TI - Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13(3):177–89. ID - ref66 ER - TY - STD TI - Sheikh HU, Pavlovic J, Loder E, Burch R. Risk of Stroke Associated With Use of Estrogen Containing Contraceptives in Women With Migraine: A Systematic Review. Headache. 2018;58(1):5-21. ID - ref67 ER -